Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer

ClinicalTrials.gov ID: NCT00116779

Public ClinicalTrials.gov record NCT00116779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Randomized, Multi-center, Parallel Group Comparison of the Efficacy and Safety of Degarelix at Two Different Dosing Regimens in Patients With Prostate Cancer Dosed for Thirteen 28-day Cycles

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study was to contribute, along with other such dose-finding studies, to the identification of the most effective treatment regimen for a one month depot injection of degarelix in the treatment of prostate cancer by a rapid and sustained suppression of testosterone.

Study identification

NCT ID
NCT00116779
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Ferring Pharmaceuticals
Industry
Enrollment
127 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2004 (Type not available)
Primary completion
Aug 2005 (Actual)
Completion
Aug 2005 (Actual)
Last update posted
Dec 19, 2011

2004 – 2005

United States locations

U.S. sites
26
U.S. states
19
U.S. cities
26
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209 —
Alaska Clinical Research Center, LLC Anchorage Alaska 99508 —
Advanced Urology Medical Center Anaheim California 92801 —
South Orange County Medical Research Cnter Laguna Woods California 92653 —
Pacific Clinical Research Santa Monica California 90404 —
West Coast Clinical Research Tarzana California 91356 —
Western Clinical Research Torrance California 90505 —
Urology Associate PC Denver Colorado 80210 —
South Florida Medical Research Aventura Florida 33180 —
SW Florida Urological Associates Fort Myers Florida 33907 —
Florida Foundation for Healthcare Research Ocala Florida 34474 —
RMD Clinical Reseach Institution LLC Melrose Park Illinois 60160 —
Northeast Indiana Research, LLC Fort Wayne Indiana 46825 —
Regional Urology Shreveport Louisiana 71106 —
Nevada Urology Associates Reno Nevada 89511 —
Lawrenceville Urology Lawrenceville New Jersey 08648 —
Hudson Valley Urology PC Poughkeepsie New York 12601 —
The Urology Center Greensboro North Carolina 27401 —
State College Urologic Association State College Pennsylvania 16801 —
Univeristy Urological Research Institute Providence Rhode Island 02904 —
Urology San Antonio Research San Antonio Texas 78229 —
Scott & White Memorial Hospital Temple Texas 76508 —
University of Vermont, Dept of Surgery South Burlington Vermont 05403 —
Virginia Urology Center Richmond Virginia 23235 —
Office of Jeffrey Frankel Seattle Washington 98166 —
Wyoming Research Foundation Cheyenne Wyoming 82001 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00116779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 19, 2011 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00116779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →